[e-drug] Emergency Buffer Stock Supply for the Supply of key HIV & AIDS Products

[e-drug@healthnet.org]

E-DRUG: Emergency Buffer Stock Supply for the Supply of key HIV & AIDS Products
------------------------------------------------------------------------
[crossposted from afro-nets with thanks. BS]

The emergency buffer stock for the supply of key HIV & AIDS products for treatment programmes in mainly Sub Sahara Africa is due to start operating from the end of this month. 

Funded by the Dutch Ministry of Foreign Affairs and Development Cooperation, this buffer stock will offer a fall-back supply service to HIV & AIDS treatment programmes in Africa that may run out of supplies for one reason or other. The Ministry has contracted IDA Solutions and its South African affiliate AA4A to implement this new service. The service will be able to mobilise stock within 24 hours and reach 80% of Sub Sahara Africa destinations within one week. The warehouse is licensed by MCC of South Africa and the business operations will be handled by the logistical service provider SMM Healthcare Enterprises (Pty) Ltd based in Johannes burg, South Africa.  

All the products to be available from the emergency buffer stock will comply with either WHO or FDA quality standards and are included in the Standard Treatment Guidelines of the receiving countries. The basic list of products currently available to start the project is composed of:
*        Lamivudine/Stavudine/Nevirapine 150mg/40mg/200mg  60 tablets
*        Lamivudine/Stavudine/Nevirapine 150mg/30mg/200mg   60 tablets
*        Lamivudine/Zidovudine/Nevirapine 150mg/300mg/200mg 60 tablets
*        Lamivudine/Zidovudine 150mg/300mg 60 tablets
*        Efavirenz 600mg 30 tablets
*        Lamivudine/Stavudine 150mg/40mg  60 tablets
*        Lamivudine/Stavudine 150mg/30mg  60 tablets
*        Nelfinavir (as mesilate) 250mg  270 tablets
*        Abacavir (as sulphate) 300mg blister (6x10) tablets
*        Tenofovir disoproxil fumarate 300mg [Viread] 30 tablets

In order to ensure the provision of the required service to HIV & AIDS treatment programmes in Sub Sahara Africa, we would like to elicit your ideas on expanding the product list, presentations and possible adaptations of the 1st line treatment regime based on your practical experience.

We would also like to hear from you what test kits and reagents need to be included in the product list on offer.

C N Kumire   
(Project Manager)

For more info contact:

Melinda Wannenburg
Assistant Management
ARV Access for Africa- 
78 Hazelwood Street
Menlo Park 0081
Pretoria
South Africa

+27 12 460 0914
+27 82 552 4227
+27 12 346 1196
mailto:Melinda@aa4a.co.za
http://www.aa4a.co.za

Letty Sithole
Office Assistant
ARV Access for Africa- 
78 Hazelwood Street
Menlo Park 0081
Pretoria
South Africa
+27 12 460 0914
+27 12 346 1196
mailto:Letty@aa4a.co.za
http://www.aa4a.co.za/